Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens.
暂无分享,去创建一个
D. Hose | H. Goldschmidt | A. Jauch | A. Ho | A. Benner | T. Bochtler | U. Hegenbart | C. Kunz | M. Granzow | A. Seckinger | C. Kimmich | S. Schönland